In this issue:
Advanced HCC in NZ
Reinfection after successful DAA for HCV among PWID
Elimination of HCV among PWID in Australia
Simplified monitoring for HCV treatment with glecaprevir/pibrentasvir
Decreased risk of HCC recurrence with DAAs for HCV
Caesarean section and nonbreastfeeding to reduce HBV transmission
Long-term outcomes after fetal exposure to tenofovir disoproxil fumarate
HBV risk score for the prediction of hepatocellular carcinoma
Antiviral therapy for HBV in different trimesters of pregnancy
The lived experience of patients with chronic HBV
Please login below to download this issue (PDF)